Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Zenas BioPharma, Inc. (ZBIO) had Return on Investments of -74.96% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-240.44M |
|
-- |
|
-- |
|
$237.98M |
|
$-237.98M |
|
$-2.35M |
|
$-240.34M |
|
$-240.34M |
|
$-240.44M |
|
$-240.44M |
|
$-240.44M |
|
$-240.44M |
|
$-237.98M |
|
$-237.97M |
|
44.73M |
|
44.73M |
|
$-5.17 |
|
$-5.17 |
|
| Balance Sheet Financials | |
$351.17M |
|
$0.03M |
|
$32.47M |
|
$383.64M |
|
$62.65M |
|
$78.64M |
|
$78.85M |
|
$141.50M |
|
$242.14M |
|
$242.14M |
|
$242.14M |
|
54.49M |
|
| Cash Flow Statement Financials | |
$-172.33M |
|
$-251.89M |
|
$215.28M |
|
$319.83M |
|
$110.64M |
|
$-209.19M |
|
$26.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.61 |
|
-- |
|
-- |
|
0.25 |
|
0.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-172.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-99.30% |
|
-99.30% |
|
-62.67% |
|
|
Return on Investments |
-74.96% |
$4.44 |
|
$-3.85 |
|
$-3.85 |
|